Blog
-
Weed Wonks Podcast: Pulak Sharma and Dr. Sean Arora on the “Wild West of CBD” and the Need for Customizable Medical Cannabis
Pulak Sharma and Dr. Sean Arora discuss the future of clinician-directed cannabinoid care, the challenges created by the federal divide between hemp and marijuana, and why understanding the direction of cannabis policy is critical for the medical market.
Read More → -
Weed Wonks Podcast: Wyld’s Gabe Parton Lee on the Challenges of Regulating Cannabis Edibles
Wyld General Counsel discusses the compliance challenges cannabis companies face, the push for federal rescheduling, and why maintaining public trust is essential for the industry’s future.
Read More → -
Weed Wonks Podcast: Attorney Jason Tarasek on Why Minnesota is the Most Fascinating Cannabis Market
Vicente LLP partner discusses Minnesota’s cannabis policies, why a unified market matters, and how rescheduling could reshape investment opportunities.
Read More → -
S64 in the News: Medical marijuana rescheduled by Feds, could open up research and tax breaks
Christian Sederberg and Mason Tvert hit the airwaves for interviews with Colorado Public Radio, KOAA NBC Colorado Springs, and KOA 850 news radio.
Read More → -
Federal Rescheduling of Medical Marijuana Advances, Hearings Set for Potential Expansion to Adult-use
The DOJ moved state-licensed medical marijuana and FDA-approved cannabis products to Schedule III, potentially creating a new federal pathway and major tax relief for medical operators.
Read More → -
Support Coalescing Behind a “One-Plant” Regulatory Framework
Strategies 64’s One-plant Solution white paper is in close alignment with the growing industry consensus around federal cannabis reform.
Read More → -
Strategies 64 partner featured on Karma Koala Podcast
S64 partner Jordan Wellington joins Karma Koala Podcast to discuss The One-plant Solution white paper.
Read More → -
Weed Wonks Podcast: Mike Hennesy of Wana Brands on the “One-plant Solution” and Bridging the Marijuana-hemp Policy Divide
The VP of Innovation for one the nation’s leading marijuana and hemp product manufacturers discusses S64’s recent white paper and the development of cGMP.
Read More → -
New Strategies 64 white paper offers a “one-plant solution” for advancing a unified national cannabis policy and regulatory framework
The proposed plan is based on extensive stakeholder outreach and details a clear and achievable path to a coherent policy that prioritizes public health and safety.
Read More →
